In Vitro Activity of a New Ketolide Antibiotic, HMR 3647, against Chlamydia pneumoniae
The in vitro activities of HMR 3647, roxithromycin, erythromycin, and azithromycin against 19 strains of Chlamydia pneumoniae were tested. The MIC at which 90% of the isolates are inhibited and the minimum bactericidal concentration at which 90% of the isolates are killed of HMR 3647 were 0.25 μg/ml...
Tallennettuna:
| Julkaisussa: | Antimicrob Agents Chemother |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology (ASM)
1998
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105635/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9624507/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.6.1515 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|